Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Castration-Resistant Prostate Cancer (mCRPC)”

389 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 389 results

Early research (Phase 1)Study completedNCT03811652
What this trial is testing

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more
MedImmune LLC 8
Large-scale testing (Phase 3)Study completedNCT04887506
What this trial is testing

TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Castration-sensitive Prostate CancerMetastatic Prostate Cancer
Tavanta Therapeutics 107
Not applicableStudy completedNCT04000776
What this trial is testing

3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Université de Sherbrooke 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05670106
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 62
Testing effectiveness (Phase 2)Looking for participantsNCT06001255
What this trial is testing

ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid Tumors

Who this might be right for
Metastasis Castration Resistant Prostate Cancer(mCRPC)
Hansoh BioMedical R&D Company 120
Large-scale testing (Phase 3)Study completedNCT03016312
What this trial is testing

Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Hoffmann-La Roche 759
Very early researchLooking for participantsNCT07156045
What this trial is testing

Study of Allogeneic Anti-PSMA CAR-NK Cell for Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Castration-resistant Prostate Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 10
Early research (Phase 1)Looking for participantsNCT06217822
What this trial is testing

First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Advanced Metastatic Castration-resistant Prostate CancerProstate Specific Membrane Antigen (PSMA) Expression
Bayer 198
Testing effectiveness (Phase 2)Ended earlyNCT02933801
What this trial is testing

ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.

Who this might be right for
Prostate Cancer MetastaticProstate Cancer
Swiss Cancer Institute 92
Testing effectiveness (Phase 2)Looking for participantsNCT05114746
What this trial is testing

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 110
Testing effectiveness (Phase 2)Study completedNCT02952534
What this trial is testing

Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
pharmaand GmbH 277
Early research (Phase 1)Active Not RecruitingNCT06104449
What this trial is testing

Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)

Who this might be right for
Prostatic NeoplasmsMetastatic Castration-Resistant Prostate Cancer
Merck Sharp & Dohme LLC 6
Testing effectiveness (Phase 2)UnknownNCT03356912
What this trial is testing

CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Consorzio Oncotech 220
Very early researchEnded earlyNCT04116164
What this trial is testing

Safety and Targeting of Anti-hk2 Antibody in mCRPC

Who this might be right for
Castration-Resistant Prostatic CancerMetastatic Disease
SpectronRX 27
Not applicableLooking for participantsNCT07118436
What this trial is testing

Liquid Biopsy Under PSMA Radioligand Therapy

Who this might be right for
Prostate Cancer Metastatic Castration-ResistantProstate Cancer
Wuerzburg University Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05383079
What this trial is testing

Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate CancerMCRPCProstate Cancer
Peter MacCallum Cancer Centre, Australia 36
Testing effectiveness (Phase 2)Ended earlyNCT05489991
What this trial is testing

TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Tceleron Therapeutics, Inc. 1
Early research (Phase 1)Looking for participantsNCT06784193
What this trial is testing

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more
Olema Pharmaceuticals, Inc. 180
Early research (Phase 1)Active Not RecruitingNCT04397276
What this trial is testing

JNJ-70218902 in Participants With Advanced Stage Solid Tumors

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 82
Testing effectiveness (Phase 2)Study completedNCT03658447
What this trial is testing

PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Peter MacCallum Cancer Centre, Australia 37
Load More Results